本页面由Tiger Trade Technology Pte. Ltd.提供服务

Altamira Therapeutics Ltd.

0.1063
0.0000
成交量:500.00
成交额:53.17
市值:60.76万
市盈率:-0.09
高:0.1063
开:0.1063
低:0.1063
收:0.1063
52周最高:0.1600
52周最低:0.0501
股本:571.55万
流通股本:464.21万
量比:0.76
换手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):-1.1900
每股收益(LYR):-2.9862
净资产收益率:-108.79%
总资产收益率:-45.75%
市净率:0.15
市盈率(LYR):-0.04

数据加载中...

2025/06/17

交易所摘牌声明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/04/30

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/04/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/16

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/09/16

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/09/16

SEC问询函

Form CORRESP - Correspondence
2024/09/16

SEC问询函

Form CORRESP - Correspondence
2024/08/22

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/07/01

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/04/22

[修订]年度报告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/04/16

SEC问询函

Form CORRESP - Correspondence
2024/04/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/04/10

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/04/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/13

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/01/17

SEC问询函

Form CORRESP - Correspondence